CALGARY,
AB, July 16, 2024 /PRNewswire/ -- Circle
Cardiovascular Imaging ("Circle" or the "Company"), the global
leader in AI-driven cardiovascular imaging solutions, today
announced that Erkan Akyuz has been appointed Chief Executive
Officer, effective August 5, 2024. He
will succeed Circle co-founder and CEO Greg
Ogrodnick, who is stepping down after successfully leading
the Company for more than 16 years.
Akyuz brings extensive leadership experience in healthcare and
imaging technology, having served as President and CEO at major
healthcare and medical systems companies including Rhapsody, Change
Healthcare and Toshiba Medical Systems, where, under his
leadership, the companies experienced improved profitability,
customer retention and growth. Recognized for his ability to
transform business models, Akyuz combines his technological
background with his strategic prowess to drive operational
excellence.
"I have long admired Circle and its role at the forefront of the
medical imaging industry, offering best-in-class AI-powered
solutions to hospitals, physicians and patients on a global scale,"
said Erkan Akyuz. "I am thrilled to be joining this impressive
team and look forward to leading Circle as we continue to advance
our mission of improving patient outcomes worldwide."
Akyuz is joining Circle, the leading provider of AI-based
cardiac imaging and reporting solutions, during a period of
accelerated growth and product innovation. Since Thoma Bravo's
investment in Circle in April 2022,
the Company has expanded its global footprint from approximately 50
countries to over 90 countries and has continued to innovate on its
cutting-edge AI-driven solutions. Earlier this year, Circle
launched its next generation platform, cvi42 6.1, which is centered
around growing with the medical field with a focus on
accessibility, interoperability and efficiency.
"On behalf of the Thoma Bravo team, I want to thank Greg
for his unwavering leadership and commitment to innovation that led
Circle to become the category leader that it is today," said
Carl Press, a Partner at Thoma
Bravo. "Under Greg's stewardship, Circle transformed from a
university-led research project into a market leading diagnostic
platform that has benefitted tens of thousands of cardiology
patients globally. We are humbled by the impact that he has made in
the world of medical imaging and are truly grateful for our
partnership with him. At the same time, we are thrilled to welcome
Erkan to Circle and look forward to working closely together as we
build on a strong foundation and continue to drive product
innovation and growth globally."
"It has been a privilege to lead the dedicated and passionate
team at Circle, and I am proud of what we have achieved together,"
said Greg Ogrodnick. "I'm confident that Erkan is the right
person to lead Circle in the next phase of its journey, and I look
forward to watching the Company's continued success."
About Circle Cardiovascular Imaging Inc.
Circle Cardiovascular Imaging (Circle) is a Canadian-based
company that was founded in 2007, established with the aim of
developing innovative software solutions to enhance cardiovascular
imaging analysis and improve patient care. Circle's imaging
platform provides best-in-class cardiovascular image reading and
reporting for cardiac MR, cardiac CT, cardiac interventional
planning, and electrophysiology.
At the heart of everything we do is our unrelenting drive to
continually offer better solutions for healthcare providers that
improve healthcare outcomes. This fuels our creativity, informs our
decisions and is the reason we are passionate about our work. Our
roots are medical and digital, our passion is contagious, and our
people are amongst the best.
Annually, millions of cardiac exams – in over 1700 hospitals and
in more than 90 countries – are estimated to be interpreted using
cvi42. For additional information, please
visit www.circlecvi.com or contact:
marketing@circlecvi.com
View original
content:https://www.prnewswire.com/news-releases/circle-cardiovascular-imaging-announces-leadership-transition-302197314.html
SOURCE Circle Cardiovascular Imaging Inc.